Additionally, the results of immunohistochemistry indicated that hBMSCs-derived miR-205 significantly decreased the RHPN2 level in prostate cancer tissues (p < 0.05) (Fig. 9b). The gene discussed is RHPN2; the disease is prostate cancer.